Segment and Related Information (Tables)

12 Months Ended

Dec. 31, 2020

Segment and Related Information

Summary of financial information concerning the Company's reporting segments

	Patient Care						Products & Services
	For the Year Ended December 31,						For the Year Ended December 31,
(in thousands)	2020		2019		2018		2020		2019		2018
Net revenue
Third party	$	831,603	$	905,691	$	857,382	$	169,547	$	192,355	$	191,378
Intersegments		—		—		—		189,604		203,496		192,096
Total net revenue		831,603		905,691		857,382		359,151		395,851		383,474
Material costs
Third party suppliers		221,566		250,407		234,409		93,844		107,364		103,608
Intersegments		25,818		24,394		23,792		163,786		179,102		168,304
Total material costs		247,384		274,801		258,201		257,630		286,466		271,912
Personnel expenses		302,206		319,633		312,736		48,985		52,592		51,353
Other expenses		115,924		151,140		140,527		24,638		28,178		24,306
Depreciation & amortization		18,892		18,541		19,113		10,173		10,650		10,197
Impairment of intangible assets		—		—		—		—		—		183
Segment income from operations	$	147,197	$	141,576	$	126,805	$	17,725	$	17,965	$	25,523
Purchase of property, plant and equipment	$	10,607	$	16,102	$	12,781	$	11,040	$	2,368	$	1,890
Purchase of therapeutic program equipment leased to third parties under operating leases	$	—	$	—	$	—	$	3,592	$	6,672	$	9,835

Schedule of reconciliation of reportable segments

A reconciliation of the total of the reportable segment’s income (loss) from operations to consolidated income from operations is as follows:

(in thousands)	2020		2019		2018
Income (loss) from operations
Patient Care	$	147,197	$	141,576	$	126,805
Products & Services		17,725		17,965		25,523
Corporate & other		(93,015)		(94,113)		(92,681)
Income from operations		71,907		65,428		59,647
Interest expense, net		32,445		34,258		37,566
Loss on extinguishment of debt		—		—		16,998
Non-service defined benefit plan expense		632		691		703
Income before income taxes		38,830		30,479		4,380
Provision for income taxes		638		2,954		5,238
Net income (loss)	$	38,192	$	27,525	$	(858)

A reconciliation of the reportable segment’s net revenue to consolidated net revenue is as follows:

(in thousands)	2020		2019		2018
Net Revenue
Patient Care	$	831,603	$	905,691	$	857,382
Products & Services		359,151		395,851		383,474
Corporate & other		—		—		—
Consolidating adjustments		(189,604)		(203,496)		(192,096)
Consolidated net revenue	$	1,001,150	$	1,098,046	$	1,048,760

A reconciliation of the reportable segment’s material costs to consolidated material costs is as follows:

(in thousands)	2020		2019		2018
Material costs
Patient Care	$	247,384	$	274,801	$	258,201
Products & Services		257,630		286,466		271,912
Corporate & other		—		—		—
Consolidating adjustments		(189,604)		(203,496)		(192,096)
Consolidated material costs	$	315,410	$	357,771	$	338,017

A reconciliation of the reportable segment’s purchase of property, plant and equipment to consolidated purchase of property, plant and equipment, including purchases of therapeutic program equipment leased to third parties under operating leases, is as follows:

(in thousands)	2020		2019		2018
Purchase of property, plant and equipment and therapeutic program equipment leased to third parties under operating leases
Patient Care	$	10,607	$	16,102	$	12,781
Products & Services
Property, plant and equipment		11,040		2,368		1,890
Therapeutic program equipment leased to third parties under operating leases		3,592		6,672		9,835
Corporate & other		2,853		7,963		4,313
Total consolidated purchase of property, plant and equipment and therapeutic program equipment leased to third parties under operating leases	$	28,092	$	33,105	$	28,819

A reconciliation of the total of the reportable segment’s assets to consolidated assets is as follows:

(in thousands)	2020		2019
Assets
Patient Care	$	578,319	$	552,644
Products & Services		121,564		105,673
Corporate & other		250,868		183,936
Total consolidated assets	$	950,751	$	842,253